Mark Attilio is a board-certified oncology pharmacist specializing in benign and malignant hematologic disorders. He completed his PharmD in 2016 with additional training in hematology oncology at University of Michigan. With his hire as a specialist for Chicago’s Northwestern Memorial Hospital in 2018, he established and evolved pharmacy support for benign hematology. Mark relocated in 2021, and as his current primary pharmacy appointment, provides local hematology oncology care for Pennsylvania Hospital. In addition, he provides benign hematology support to the greater University of Pennsylvania Health System as their benign pharmacy specialist.